Skip to main content
Back to HSG

HSG's Therapeutics Portfolio

Browse 14 Therapeutics companies funded by HSG. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
14
Total Funding in Therapeutics
$608.4M

Therapeutics Portfolio Companies (14)

Export
BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

South San Francisco, United States
April 2025
$8.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

Excalipoint Therapeutics develops targeted therapies that focus on modulating disease pathways at specific biological points.

Admiralty, Hong Kong
March 2026
$27.7M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.

Princeton, United States
February 2026
$85.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyTherapeutics

Alternative Bio is a biotechnology company focused on developing novel therapeutics targeting a post-translational modifying enzymes.

China, Japan
February 2025
Corporate Round

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

New Haven, United States
January 2025
$75.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife SciencePharmaceuticalTherapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

New Haven, United States
January 2022
$40.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases

San Diego, United States
January 2024
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

Suzhou, China
July 2025
$25.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

Health CareRoboticsTherapeutics

YuanHua Zhineng is a developer of orthopedic surgery robots.

Shenzhen, China
March 2021
$30.7M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareOncologyTherapeutics

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

Shanghai, China
June 2020
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

Refuge Biotechnologies therapeutic company focused on gene editing and genetic engineering of immune cells for cancer immunotherapy.

Menlo Park, United States
May 2018
$25.0M
Series B

Founder Contacts

30,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio